Predicting transformation in follicular lymphoma

Leukemia and Lymphoma

Volumn 50, Issue 9, 2009, Pages 1406-1411

  De Jong, Daphne ^a   De Boer, Jan Paul ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

diffuse large B cell lymphoma; Follicular lymphoma; predictive assay; transformation

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 8; INTERLEUKIN RECEPTOR;

BURKITT LYMPHOMA; CANCER GENETICS; CANCER MORPHOLOGY; FOLLICULAR LYMPHOMA; GENETIC VARIABILITY; HUMAN; INCIDENCE; LARGE CELL LYMPHOMA; MALIGNANT TRANSFORMATION; MUTATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC HYPERMUTATION; TUMOR CELL; TUMOR MICROENVIRONMENT; CELL TRANSFORMATION; DISEASE COURSE; GENETICS; PATHOLOGY; PROGNOSIS;

CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; HUMANS; INCIDENCE; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; PROGNOSIS;

EID: 77955357487     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190903093815     Document Type: Review

References (42)

1. Rosenberg SA. Follicular lymphoma revisited. J Clin Oncol 2008;26:515-516. (Pubitemid 351264340)
2. Montoto S, Davies AJ, Matthews J, et al. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. J Clin Oncol 2007;25:1-8.
3. Al-Tourah AJ, Gill KK, Chhanabhai M, et al. Populationbased analysis of incidence and outcome of transformed non-Hodgkin lymphoma. J Clin Oncol 2008;26:5165-5169.
4. Horning SJ, Rosenberg SA. The natual history of initially untreated low-grade non-Hodgkin lymphomas. N Engl J Med 1984;311:1471-1475. (Pubitemid 15211022)
5. Jaffe E, Harris NL, Stein H, et al. WHO classification of tumours of haematological and lymphoid tissues. Lyon: IARC Press; 2001.
6. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.
7. Glas AM, Knoops L, Delahaye L, et al. ASH Annual Meeting Abstract. 2006:108:823.
8. de Jong D, Voetdijk B H M, Beverstock GC, et al. Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma presenting as a composite lymphoma. N Engl J Med 1988;318:1373.
9. Yano T, Jaffe ES, Longo DL, et al. MYC rearrangements in histologically progressed follicular lymphomas. Blood 1992;80:758-767.
10. Haralambieva E, Boerma EJ, van Imhoff GW, et al. Clinical, immunophenotypic and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am J Surg Pathol 2005;29:1086-1094. (Pubitemid 41045555)
11. McClure RF, Remstein ED, Macon WR, et al. Adult B-cell lymphomas with Burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior. Am J Surg Pathol 2005;29:1652-1660.
12. Le Gouill S, Talmant P, Touzeau C, et al. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t (14;18) and 8q24/c-MYC rearrangement. Haematologica 2007;92:1335-1342. (Pubitemid 350144150)
13. Kanungo A, Medeiros LJ, Abruzzo LV, et al. Lymphoid neoplasms associated with concurrent t (14;18) and 8q24/c-MYC translocation generally have a poor prognosis. Mod Pathol 2006:19;25-33. (Pubitemid 43250976)
14. Kramer M H H, Raghoebier S, Beverstock GC, et al. De novo acute B-cell leukemia with translocation t (14;18): an entity with a poor prognosis. Leukemia 1999;14:1960-1966.
15. Horsman DE, Connors JM, Pantzar T, et al. Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t (14;18). Genes Chrom Cancer 2001;30:375-382. (Pubitemid 32216328)
16. Höglund M, Sehn L, Connors JM, et al. Identification of cytogenetic subgroups and karyotype pathways of clonal evolution in follicular lymphomas. Genes Chrom Cancer 2004;39:195-204. (Pubitemid 38209580)
17. D'Amore F, Chan E, Iqbal J, et al. Clonal evolution in t (14;18) positive follicular lymphoma, evidence for multiple common pathways and frequent parallel clonal evolution. Clin Can Res 2008;14:7180-7187.
18. Elenitoba-Johnson K S J, Gascoyne RD, Lim MS, et al. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histological progression in follicle center lymphoma. Blood 1998;91:4677-4685. (Pubitemid 28270317)
19. Lossos IS, Levy R. Higher grade transformation of follicle center lymphoma is associated with somatic mutation of the 50 non-coding regulatory region of the bcl-6 gene. Blood 2000;96:635-639. (Pubitemid 30463385)
20. Lo Cocco F, Gaidano G, Louie DC, et al. P53 mutations are associated with histological transformation of follicular lymphoma. Blood 1993;82:2289-2295. (Pubitemid 23304250)
21. Davies AJ, Lee AM, Taylor C, et al. A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma. Leukemia 2005;19:1459-1465. (Pubitemid 41136342)
22. Martinez-Climent JA, Alizadeh AA, Segraves R, et al. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood 2003;101:3109-3117. (Pubitemid 36858004)
23. Glas AM, Kersten MJ, Delahaye L J M J, et al. Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. Blood 2005;105:301-307. (Pubitemid 40053097)
24. De Vos S, Hofman WK, Grogan TM, et al. Gene expression profile of serial samples of transformed B-cell lymphoma. Lab Invest 2003;83:271-285. (Pubitemid 36255371)
25. LeBrun D, Baetz T, Foster C, et al. Predicting outcome in follicular lymphoma using interactive gene pairs. Clin Cancer Res 2008;14:478-487. (Pubitemid 351226116)
26. Lossos IS, Alizadeh AA, Diehn M, et al. Transformation of follicular lymphoma to diffuse large cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc Natl Acad Sci USA 2002;99:8886-8891. (Pubitemid 34693653)
27. Davies AJ, Rosenwald A, Wright GW, et al. Transformation of follicular lymphoma to diffuse large cell lymphoma proceeds by distinct oncogenic mechanisms. Br J Haematol 2006;136:286-293.
28. Maesako Y, Uchiyama T, Ohno H. Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt lymphoma and de novo diffuse large B-cell lymphoma. Cancer Sci 2003;94:774-781. (Pubitemid 37258775)
29. Carlotti E, Wrench D, Matthews J, et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone. Blood 2009;113:3553-3557.
30. Ruminy P, Jardin F, Picquenot F, et al. Sm mutation patterns suggest different progression pathways in follicular lymphoma: early direct or late from FL progenitor cells. Blood 2008;112:1951-1959.
31. O'Shea D, Riain CO, Gupta M, et al. Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation. Blood 2009;113:2298-2301.
32. Glas AM, Knoops L, Delahaye L, et al. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol 2007;25:390-398. (Pubitemid 350002987)
33. Farinha P, Masoudi H, Skinnider BF, et al. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood 2005;106:2169-2174. (Pubitemid 41291735)
34. Lee AM, Clear AJ, Calaminici M, et al. Number of CD4+ cells and location of forkhead box protein P3-poitive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. J Clin Oncol 2006; s24:5052-5059. (Pubitemid 46631409)
35. Alvaro T, Lejeune M, Salvado M-T, et al. Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients. J Clin Oncol 2006;24:5350-5357. (Pubitemid 46623165)
36. Carreras J, Lopez-Guillermo A, Fox BC, et al. High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 2006;108:2957-2964.
37. Canioni D, Salles G, Mounier N, et al. High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. J Clin Oncol 2008;26:440-446. (Pubitemid 351171697)
38. De Jong D. Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol 2005;23:6358-6363. (Pubitemid 46218847)
39. Cerhan JR, Ansell SM, Fredericksen ZS, et al. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 2007:110:4455-4463. (Pubitemid 351377812)
40. Rothman N, Skibola CF, Wang SS, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the Inter Lymph Consortium. Lancet Oncol 2005;7:27-38. (Pubitemid 43025390)
41. Cerhan JR, Wang S, Mauer MJ, et al. Prognostic significance of host gene polymorphisms in follicular lymphoma. Blood 2007;109:5439-5446. (Pubitemid 46890567)
42. Ekstrom K, Lindgren CM, Hjargrim H, et al. Variation in DNA repair genes ERCC1, XRCC1 and XRCC3 and risk of follicular lymphoma. Cancer Epidemiol Biomarkers Prev 2006;15:258-265. (Pubitemid 43342172)